Bpifrance Participations, Innate Pharma board director, purchases EUR 3 million of Innate Pharma shares

• Innate Pharma announced Bpifrance Participations, a board member represented by Olivier Martinez, subscribed for 1,764,705 shares at EUR 1.7.
• The purchase took place outside a trading venue.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Innate Pharma SA published the original content used to generate this news brief on August 14, 2026, and is solely responsible for the information contained therein.